Tower Research Capital LLC (TRC) - MERSANA THERAPEUTICS INC ownership

MERSANA THERAPEUTICS INC's ticker is MRSN and the CUSIP is 59045L106. A total of 107 filers reported holding MERSANA THERAPEUTICS INC in Q4 2023. The put-call ratio across all filers is 0.03 and the average weighting 0.2%.

Quarter-by-quarter ownership
Tower Research Capital LLC (TRC) ownership history of MERSANA THERAPEUTICS INC
ValueSharesWeighting
Q2 2024$81,927
+2130.5%
40,760
+4870.7%
0.00%
Q1 2024$3,673
-93.5%
820
-96.7%
0.00%
-100.0%
Q4 2023$56,917
-7.2%
24,533
-49.2%
0.00%
-50.0%
Q3 2023$61,352
+151.9%
48,309
+552.6%
0.00%
+100.0%
Q2 2023$24,355
+25269.8%
7,403
-68.4%
0.00%
-66.7%
Q1 2023$96
-55.3%
23,450
-36.1%
0.00%
-66.7%
Q4 2022$215
-99.9%
36,698
+0.8%
0.01%
+125.0%
Q3 2022$246,000
+530.8%
36,410
+328.8%
0.00%
+300.0%
Q2 2022$39,000
+14.7%
8,492
+0.8%
0.00%
Q1 2022$34,000
-72.6%
8,425
-57.5%
0.00%
-100.0%
Q4 2021$124,000
+51.2%
19,846
+128.3%
0.00%0.0%
Q3 2021$82,000
+3.8%
8,693
+49.2%
0.00%0.0%
Q2 2021$79,000
-42.3%
5,825
-31.5%
0.00%0.0%
Q1 2021$137,000
+661.1%
8,501
+1153.8%
0.00%
+100.0%
Q4 2020$18,000
-85.7%
678
-90.0%
0.00%0.0%
Q3 2020$126,000
-43.5%
6,791
-28.6%
0.00%
-88.9%
Q2 2020$223,000
+5475.0%
9,512
+1128.9%
0.01%
Q4 2019$4,000
-66.7%
774
-89.8%
0.00%
-100.0%
Q3 2019$12,000
-14.3%
7,568
+125.9%
0.00%0.0%
Q2 2019$14,000
+75.0%
3,350
+116.1%
0.00%
Q1 2019$8,000
-82.2%
1,550
-85.8%
0.00%
-100.0%
Q4 2018$45,000
+18.4%
10,929
+189.1%
0.00%0.0%
Q3 2018$38,000
-2.6%
3,781
+72.6%
0.00%
+50.0%
Q2 2018$39,000
+680.0%
2,190
+622.8%
0.00%
Q3 2017$5,0003030.00%
Other shareholders
MERSANA THERAPEUTICS INC shareholders Q4 2023
NameSharesValueWeighting ↓
Bain Capital Life Sciences Investors, LLC 8,663,673$28,503,4842.94%
Logos Global Management LP 2,800,000$9,212,0001.25%
SILVERARC CAPITAL MANAGEMENT, LLC 1,100,000$3,619,0001.12%
5AM Venture Management, LLC 1,305,000$4,293,4501.07%
SILVERARC CAPITAL MANAGEMENT, LLC 1,000,000$3,290,0001.02%
Decheng Capital Management III (Cayman), LLC 904,268$2,975,0420.93%
Sarissa Capital Management LP 2,632,900$8,662,2410.86%
DAFNA Capital Management LLC 810,845$2,667,6800.73%
Tri Locum Partners LP 428,307$1,409,1300.52%
Avidity Partners Management LP 3,790,000$12,469,1000.44%
View complete list of MERSANA THERAPEUTICS INC shareholders